SCHEMBL17653173

SCHEMBL17653173

CCc1nc(N(CCC(C)C)C(=O)OCc2ccccc2)nc2cc(OC)c(-c3cnco3)cc12

nearest known ligand 0.51

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
AAK1 Q2M2I8 10/20 0.51
IMPDH2 P12268 11/20 0.41
IMPDH1 P20839 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17653184 0.89 AAK1 (0.53) AAK1IMPDH2
SCHEMBL17653279 0.88 AAK1 (0.58) AAK1IMPDH2IMPDH1
SCHEMBL17653108 0.86 AAK1 (0.49) AAK1
SCHEMBL17653413 0.86 AAK1 (0.54) AAK1IMPDH2
SCHEMBL17653347 0.85 AAK1 (0.41) AAK1IMPDH2
SCHEMBL17653094 0.85 AAK1 (0.38) AAK1
SCHEMBL17653110 0.84 IMPDH2 (0.46) AAK1IMPDH2IMPDH1
SCHEMBL17653141 0.82 AAK1 (0.38) AAK1
SCHEMBL17653187 0.82 AAK1 (0.46) AAK1
SCHEMBL17653133 0.81 AAK1 (0.42) AAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3200797-A1 QUINAZOLINE-BASED KINASE INHIBITORS Bristol-Myers Squibb Company (US) 2017-08-09 EP disclosed
WO-2016053794-A1 QUINAZOLINE-BASED KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2016-04-07 WO disclosed